My interests

Receive our interest that have beensaved and send them to one of your contacts by entering a valid email address :

Sign up to our news and newsletters

Sign me up to these newsletters:

  • Capital Market

  • Civil Business Law

  • Civil Liability

  • Competition-Distribution Law

  • Employment Law

  • IARD (Fire, Accidents and Multi-Risk) Insurance

  • Insurance/Construction

  • Medical Liability

  • Public Law

Sign me up to these Brèves:

  • Brèves d'actualités

  • News flashes

Confirm

Thank you, you are registered

(0)

Associates

Pauline
  • Paris

Abadia
  • Paris

Languages : French, English

Paris Bar (2016)
Associate at Racine since 2024

Contact :

Tel : +33 (0)1 44 82 43 00

Add to my interests

Career

Fides Partners, associate Private Equity – M&A (2022-2023)

Ayache, associate Private Equity – M&A (2016-2022)

DLA Piper, intern (2016)

AXA Investment Managers, legal internship (2016)

Education

MS International Law and Management, ESCP EUROPE in partnership with City Law School, London (UK) (2013-2014)

Master 2 in Business Law – European Lawyer, University of Paris X – Nanterre  (2012-2013)

Master 1 English Law/Comparative Law, University College London (2011-2012)

Team's
recongnitions

Rankings

  • Chambers - 2025: Corporate – M&A
  • Legal 500 - 2024: Private equity – Fund formation
  • Chambers - 2024: Mergers and acquisitions
  • Legal 500 - 2024: Private equity – LBO
  • Chambers - 2024: General Business Law France Regions
  • Chambers - 2024: Corporate/M&A Mid-Market
  • Magazine des Affaires - 2024: Private Equity – LBO
  • Magazine des Affaires - 2024: Corporate M&A
  • Magazine des Affaires - 2024: M&A : Structuring fiscal en LBO

Awards

  • 2023: Sommet du Droit

    LBO, lower mid & small cap transactions

The team

01 / 26
View all our teams

News and latest publications

Press releases

13/01/25

Racine advises Weinberg Capital Partners on majority investment in Cosmogen

Paris, 13 January 2025 – Racine has advised Weinberg Capital Partners, a prestigious independent investment firm, on its acquisition of a majority stake in Cosmogen, the world expert in innovative, patented and responsible solutions for the application of cosmetic and pharmaceutical products....
Read more
View all

Receive our information

Confirm